These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1178 related items for PubMed ID: 11518454

  • 1. Treatment of menorrhagia with a novel 'frameless' intrauterine levonorgestrel-releasing drug delivery system: a pilot study.
    Wildemeersch D, Schacht E.
    Eur J Contracept Reprod Health Care; 2001 Jun; 6(2):93-101. PubMed ID: 11518454
    [Abstract] [Full Text] [Related]

  • 2. Treatment of primary and secondary dysmenorrhea with a novel 'frameless' intrauterine levonorgestrel-releasing drug delivery system: a pilot study.
    Wildemeersch D, Schacht E, Wildemeersch P.
    Eur J Contracept Reprod Health Care; 2001 Dec; 6(4):192-8. PubMed ID: 11848648
    [Abstract] [Full Text] [Related]

  • 3. The Femilis LNG-IUS: contraceptive performance-an interim analysis.
    Wildemeersch D, Janssens D, Andrade A.
    Eur J Contracept Reprod Health Care; 2009 Apr; 14(2):103-10. PubMed ID: 19340705
    [Abstract] [Full Text] [Related]

  • 4. Contraception with a novel 'frameless' intrauterine levonorgestrel-releasing drug delivery system: a pilot study.
    Wildemeersch D, Schacht E.
    Eur J Contracept Reprod Health Care; 2000 Dec; 5(4):234-40. PubMed ID: 11245550
    [Abstract] [Full Text] [Related]

  • 5. The effect on menstrual blood loss in women with uterine fibroids of a novel "frameless" intrauterine levonorgestrel-releasing drug delivery system: a pilot study.
    Wildemeersch D, Schacht E.
    Eur J Obstet Gynecol Reprod Biol; 2002 Apr 10; 102(1):74-9. PubMed ID: 12039094
    [Abstract] [Full Text] [Related]

  • 6. Assessment of menstrual blood loss in Belgian users of a new T-shaped levonorgestrel-releasing intrauterine system.
    Wildemeersch D, Rowe PJ.
    Contraception; 2005 Jun 10; 71(6):470-3. PubMed ID: 15914139
    [Abstract] [Full Text] [Related]

  • 7. [The role of copper-releasing intrauterine device or levonorgestrel-releasing intrauterine system on uterine bleeding and iron status (prospective study of 8 years)].
    Imperato F, Perniola G, Mossa B, Marziani R, Perniola F, Stragapede B, Napolitano C.
    Minerva Ginecol; 2002 Jun 10; 54(3):271-8. PubMed ID: 12063443
    [Abstract] [Full Text] [Related]

  • 8. Assessment of menstrual blood loss in Brazilian users of the frameless copper-releasing IUD with copper surface area of 330 mm2 and the frameless levonorgestrel-releasing intrauterine system.
    Andrade AT, Souza JP, Andrade GN, Rowe PJ, Wildemeersch D.
    Contraception; 2004 Aug 10; 70(2):173-7. PubMed ID: 15288225
    [Abstract] [Full Text] [Related]

  • 9. Menstrual blood loss in women using the frameless FibroPlant LNG-IUS.
    Andrade A, Wildemeersch D.
    Contraception; 2009 Feb 10; 79(2):134-8. PubMed ID: 19135571
    [Abstract] [Full Text] [Related]

  • 10. Review of clinical experience with the frameless LNG-IUS for contraception and treatment of heavy menstrual bleeding.
    Wildemeersch D, Andrade A.
    Gynecol Endocrinol; 2010 May 10; 26(5):383-9. PubMed ID: 20192899
    [Abstract] [Full Text] [Related]

  • 11. Levonorgestrel-releasing intrauterine device versus hysteroscopic endometrial resection in the treatment of dysfunctional uterine bleeding.
    Crosignani PG, Vercellini P, Mosconi P, Oldani S, Cortesi I, De Giorgi O.
    Obstet Gynecol; 1997 Aug 10; 90(2):257-63. PubMed ID: 9241305
    [Abstract] [Full Text] [Related]

  • 12. Contraception and treatment in the perimenopause with a novel "frameless" intrauterine levonorgestrel-releasing drug delivery system: an extended pilot study.
    Wildemeersch D, Schacht E, Wildemeersch P.
    Contraception; 2002 Aug 10; 66(2):93-9. PubMed ID: 12204781
    [Abstract] [Full Text] [Related]

  • 13. Intrauterine devices: an effective alternative to oral hormonal contraception.
    Prescrire Int; 2009 Jun 10; 18(101):125-30. PubMed ID: 19637436
    [Abstract] [Full Text] [Related]

  • 14. Predictors of oligoamenorrhea at 1-year follow-up in premenopausal women using a levonorgestrel-releasing intrauterine system.
    de Jonge ET, Yigit R, Molenberghs G, Straetmans D, Ombelet W.
    Contraception; 2007 Aug 10; 76(2):91-5. PubMed ID: 17656176
    [Abstract] [Full Text] [Related]

  • 15. Endometrial suppression with a new 'frameless' levonorgestrel releasing intrauterine system in perimenopausal and postmenopausal women: a pilot study.
    Wildemeersch D, Schacht E.
    Maturitas; 2000 Jul 31; 36(1):63-8. PubMed ID: 10989243
    [Abstract] [Full Text] [Related]

  • 16. Ease of insertion, contraceptive efficacy and safety of new T-shaped levonorgestrel-releasing intrauterine systems.
    Wildemeersch D, Janssens D, Vrijens M, Weyers S.
    Contraception; 2005 Jun 31; 71(6):465-9. PubMed ID: 15914138
    [Abstract] [Full Text] [Related]

  • 17. Uterine volume and menstrual patterns in users of the levonorgestrel-releasing intrauterine system with idiopathic menorrhagia or menorrhagia due to leiomyomas.
    Magalhães J, Aldrighi JM, de Lima GR.
    Contraception; 2007 Mar 31; 75(3):193-8. PubMed ID: 17303488
    [Abstract] [Full Text] [Related]

  • 18. Assessment of menstrual blood loss in women with ideopathic menorrhagia using the frameless levonorgestrel-releasing intrauterine system.
    Wildemeersch D, Rowe PJ.
    Contraception; 2004 Aug 31; 70(2):165-8. PubMed ID: 15288223
    [Abstract] [Full Text] [Related]

  • 19. A randomised trial comparing the levonorgestrel intrauterine system and thermal balloon ablation for heavy menstrual bleeding.
    Busfield RA, Farquhar CM, Sowter MC, Lethaby A, Sprecher M, Yu Y, Sadler LC, Brown P, Johnson N.
    BJOG; 2006 Mar 31; 113(3):257-63. PubMed ID: 16487195
    [Abstract] [Full Text] [Related]

  • 20. Levonorgestrel-releasing IUD as a method of contraception with therapeutic properties.
    Luukkainen T, Toivonen J.
    Contraception; 1995 Nov 31; 52(5):269-76. PubMed ID: 8585882
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 59.